Richard E. Rothman, M.D., Ph.D.

Principal InvestigatorPACER

Richard Rothman, M.D., Ph.D., is the primary investigator on the Clinical Utility of Preemptive Surge Measures Enacted as a Result of Conventional and Internet-Based Influenza Surveillance project, also known as the "Google Flu" project.

For the PACER program Rothman's team has focused on evaluation of the utility of surveillance for guiding health system planning and response. Work in the first phase of the program included national surveys with health departments and focus groups with local state, and federal representatives. Current studies evaluate novel surveillance systems (particularly Google flu trends) for their reliability and utility at the local level. Research includes primary data analysis and convening of expert consensus meetings. Rothman and team's findings have been published in Clinical Infectious Diseases and highlighted by multiple new organizations, including NPR.

Rothman oversees a translational research program focusing on infectious diseases in acute care settings, with studies in epidemiology, diagnostic test development and implementation, and the public health implications of infectious diseases from an emergency care perspective. His studies are translational and cross-cutting. Work has been published in leading journals in the field, including Lancet ID, JID, J Clin Micro, Annals of Emergency Medicine and Academic Emergency Medicine.

Rothman is the research director for the Johns Hopkins Department of Emergency Medicine and professor of Emergency Medicine. In addition to his role in the PACER program, Rothman is also the diagnostics lead for the Mid-Atlantic Regional Center for Excellence in Emerging and Biothreat Diseases and CoI on several NIAID projects involving diagnosis and evaluation of infectious diseases in emergency settings. He is also a member of the CDC Emerg ID Net Study Group.

Rothman's other research interests include Molecular Diagnostic Test Development, Rapid Detection of Emerging Infection; Infectious Disease Surveillance; Clinical Decision Guidelines; HIV testing and HIV-related illnesses.